Where does Acadia Pharmaceuticals's cash flow data come from?

Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	$375.65M+64.1%	$391M+72.7%	$261.17M+103%	$222.16M+627%	$228.88M+13,485%
Depreciation and amortization	$913K+0.7%	$871K-5.3%	$895K-7.3%	$894K-18.7%	$907K-28.9%
Stock-based compensation	$55.45M-12.9%	$52.14M-22.2%	$49.35M-33.9%	$62.33M-7.0%	$63.68M-4.2%
Deferred income taxes	——	——	——	——	$0—
Change in accounts receivable	$29.61M+168%	$22.72M+4,713%	$17.64M+226%	$3.81M-82.6%	$11.04M-61.6%
Change in inventories	$8.91M-79.4%	$19.45M-60.8%	$18.98M-68.5%	$20.31M-71.0%	$43.36M-5.6%
Change in accounts payable	-$5.85M-373%	-$5.29M-291%	$2.67M-60.6%	$215K-79.9%	-$1.24M-165%
Change in accrued liabilities	$4.41M-92.5%	-$19.27M-127%	$79.9M+1.9%	$65.37M-30.0%	$58.75M-27.3%
Change in other assets	$3.29M-80.8%	$3.85M-76.8%	$18.71M+6.7%	$17.9M—	$17.18M—
Change in other liabilities	-$7.33M-184%	$1.08M-62.8%	-$1.43M-154%	$16.19M+421%	$8.69M+45.6%
Change in prepaid expenses	——	——	——	——	——
Amortization of intangible assets	$10.89M-12.2%	$10.89M-27.2%	$13.16M+16.0%	$12.78M+23.3%	$12.4M+32.2%
Change in receivables	$5.06M—	$20.82M—	——	——	——
Net cash from operating activities	——	——	$198.95M-1.9%	$187.91M+133%	$148.96M+134%
Capital expenditures	$9.9M—	$4.69M—	$1.14M—	$820K—	——
Purchases of investments	$551.56M-5.1%	$692.57M+37.1%	$670.71M+41.7%	$617.65M+72.0%	$580.95M+51.6%
Proceeds from maturities/sales of investments	$449.23M+14.2%	$493.53M+50.2%	$499.63M+55.9%	$443.14M+42.7%	$393.25M+66.3%
Purchases of intangible assets	——	——	——	——	$98.84M+229%
Net cash from investing activities	-$112.23M—	-$302.56M—	——	——	——
Proceeds from issuance of common stock	$52.28M+584%	$49.88M+629%	$29.19M+183%	$20.03M-12.1%	$7.64M-69.1%
Net cash from financing activities	$52.28M+584%	$49.88M+629%	$29.19M+183%	$20.03M-12.1%	$7.64M-69.1%
Effect of exchange rate changes on cash	$56K+154%	$26K+128%	-$41K+10.9%	-$83K-938%	-$104K-845%
Net increase (decrease) in cash	——	——	——	——	$15.95M+119%
Income taxes paid	——	$25.17M+28.9%	$23.76M+47.5%	$22.35M+76.1%	$20.93M+126%
Accretion (Amortization) of Discounts and Premiums, Investments	$3.76M-61.0%	$5.42M-41.7%	$7.57M-8.4%	$9.22M+22.6%	$9.63M+36.6%
Amortization of capitalized software and acquired intangible assets	$10.89M-12.2%	$10.89M-27.2%	$13.16M+16.0%	$12.78M+23.3%	$12.4M+32.2%
Depreciation	$913K+0.7%	$871K-5.3%	$895K-7.3%	$894K-18.7%	$907K-28.9%
Gain (Loss) on Disposition of Other Assets	——	$0-100%	$36.63M-66.7%	$73.26M0.0%	$109.89M+200%
Increase (Decrease) in Accounts Receivable and Other Operating Assets	$5.06M—	$20.82M—	——	——	——
Increase Decrease In Operating Lease Assets	-$8.69M-10.3%	-$8.67M-15.5%	-$8.85M-50.9%	-$8.11M-34.9%	-$7.88M-35.8%
Increase Decrease In Operating Lease Liabilities	-$9.07M-18.8%	-$6.52M+16.4%	-$3.6M+58.4%	-$7.12M-54.2%	-$7.64M-90.7%
Increase (Decrease) in Other Operating Assets	$2.3M+392%	$2.86M+2,541%	$2.01M+1,829%	$1.19M—	$468K—
Increase (Decrease) in Prepaid Expense	——	——	——	——	——
Payments to Acquire Intangible Assets	——	——	——	——	$98.84M+229%
Proceeds From Sale And Maturity Of Available For Sale Securities	$449.23M+14.2%	$493.53M+50.2%	$499.63M+55.9%	$443.14M+42.7%	$393.25M+66.3%
Accrued Inventory Purchases	——	——	——	——	——
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations	$56K+154%	$26K+128%	-$41K+10.9%	-$83K-938%	-$104K-845%
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1	——	$0—	$48.84M—	——	——
Property And Equipment Purchases In Accrued Liabilities	——	——	——	——	——
Stock Based Compensation Capitalized	——	——	——	$539K+131%	$325K+28.3%
Income Taxes Paid, Net	——	$25.17M+28.9%	$23.76M+47.5%	$22.35M+76.1%	$20.93M+126%
Free cash flow	——	——	$197.81M—	$187.09M—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Acadia Pharmaceuticals's cash flow data come from?: Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.